The pervasiveness of diabetes type 1 and type 2 has had a notable impact on people's well-being and hampered the healthcare system's sustainability. A study forecasts that around 783.7 million people will live with diabetes by 2045. Strain diabetes puts on the economy and the complications linked to the disease have warranted a holistic approach to develop strategies to minimize prevalence and foster healthcare. There is a general acceptance that physical activity and healthy food habits could reduce obesity rates and diabetes risks.
Researchers, manufacturers and other stakeholders are navigating growth and opportunities in diabetes devices and treatment. The development of advanced treatment options could be pronounced amid the aging population. A healthy lifestyle and better diabetes medications are expected to make a difference in minimizing diabetes. The final report, coupled with the database, will deep-dive into the following dynamics:
• Decision-making process and customer buying pattern.
• Reimbursement landscape and diabetes-related expenditure per person.
• Treatment options and related costs across countries.
• Comparative prevalence of diabetes.
Get your copy or request a free sample of the report “Disease Demographics for Diabetes Type 1 and Type 2, 2023,” compiled and published by Grand View Research.
Disease Demographics for Diabetes Type 1 and Type 2 Report Scope
Patient Demographics
Total Population
People with diabetes
People with undiagnosed diabetes
Deaths attributable to diabetes
Treatment Options
Type 1 Diabetes
Insulin
Diet
Blood glucose monitoring
Type 2 Diabetes
Oral Medications
Diet
Exercise
Blood glucose monitoring
Insulin
Treatment Cost Per Patient
Total diabetes-related health expenditure, USD Million
Diabetes-related health expenditure per person, USD
Quality of Life
Disability-adjusted life years (DALYs)
Comorbidity Analysis
Diabetic foot ulcer
Cardiovascular disease (CVD)
Diabetic retinopathy
Diabetic neuropathy
Diabetic nephropathy
Reimbursement Differences
Coverage for Medicare and Medicaid
Type 1 Diabetes
Type 2 Diabetes
Related Reports:
About Us
Grand View Research, Inc. is a market research and consulting company that provides off-the-shelf, customized research reports and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and energy. With a deep-seated understanding of varied business environments, Grand View Research provides strategic objective insights.
Find More information @ https://www.grandviewresearch.com/info/trend-reports